131I-mAbG250

N/A

Report date: 2025/10/20 14:38:39

Base Information

Drug Name131I-mAbG250

Drug Alias NameIodine 131-labeled monoclonal antibody (mAb) G250

ClassificationRadiation-emitting products > Nuclides > Iodine > 131IRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionCarbonic anhydrase IX binders

TargetsCarbonic anhydrase IX

Therapy Area/IndicationsCarcinoma, Renal Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesLudwig Institute For Cancer Research

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLudwig Institute For Cancer Research

Active IndicationsN/A

Inactive IndicationsCarcinoma, Renal Cell

Other Information

ATC CodeN/A